Suppressed prostate epithelial development with impaired branching morphogenesis in mice lacking stromal fibromuscular androgen receptor

Molecular Endocrinology

Volumn 26, Issue 1, 2012, Pages 52-66

  Lai, Kuo Pao ^a   Yamashita, Shinichi ^a   Vitkus, Spencer ^a   Shyr, Chih Rong ^a,b   Yeh, Shuyuan ^a   Chang, Chawnshang ^a,b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; PHOSPHOPROTEIN; PLACENTAL GROWTH FACTOR; SOMATOMEDIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRANCHING MORPHOGENESIS; CELL GROWTH; CELL IMMORTALIZATION; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; FIBROBLAST; HOMEOSTASIS; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROSTATE EPITHELIUM; SMOOTH MUSCLE FIBER; STROMA CELL; TUMOR GROWTH; WILD TYPE;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; EPITHELIAL CELLS; EPITHELIUM; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MORPHOGENESIS; MYOCYTES, SMOOTH MUSCLE; ORGAN SIZE; PARACRINE COMMUNICATION; PHOSPHOPROTEINS; PREGNANCY PROTEINS; PROSTATE; RECEPTORS, ANDROGEN; RECOMBINANT PROTEINS; STROMAL CELLS;

MUS;

EID: 84855215970     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2011-1189     Document Type: Article

References (57)

1. Cunha GR, Chung LW, Shannon JM, Taguchi O, Fujii H 1983 Hormone-induced morphogenesis and growth: role of mesenchymal-epithelial interactions. Recent Prog Horm Res 39:559-598.
2. Cunha GR, Chung LW 1981 Stromal-epithelial interactions-I. Induction of prostatic phenotype in urothelium of testicular feminized (Tfm/y) mice. J Steroid Biochem 14:1317-1324
3. Cunha GR, Cooke PS, Kurita T 2004 Role of stromal-epithelial interactions in hormonal responses. Arch Histol Cytol 67:417-434.
4. Cunha GR, Ricke W, Thomson A, Marker PC, Risbridger G, Hayward SW, Wang YZ, Donjacour AA, Kurita T 2004 Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development. J Steroid Biochem Mol Biol 92:221-236.
5. Thomson AA 2008 Mesenchymal mechanisms in prostate organogenesis. Differentiation 76:587-598.
6. Kinbara H, Cunha GR 1996 Ductal heterogeneity in rat dorsallateral prostate. Prostate 28:58-64.
7. Hayward SW, Haughney PC, Rosen MA, Greulich KM, Weier HU, Dahiya R, Cunha GR 1998 Interactions between adult human prostatic epithelium and rat urogenital sinus mesenchyme in a tissue recombination model. Differentiation 63:131-140.
8. Marker PC, Donjacour AA, Dahiya R, Cunha GR 2003 Hormonal, cellular, and molecular control of prostatic development. Dev Biol 253:165-174.
9. Thompson TC, Cunha GR, Shannon JM, Chung LW 1986 Androgen-induced biochemical responses in epithelium lacking androgen receptors: characterization of androgen receptors in the mesenchymal derivative of urogenital sinus. J Steroid Biochem 25:627-634.
10. Wu CT, Altuwaijri S, Ricke WA, Huang SP, Yeh S, Zhang C, Niu Y, Tsai MY, Chang C 2007 Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor. Proc Natl Acad Sci USA 104:12679-12684.
11. Cunha GR 1976 Epithelial-stromal interactions in development of the urogenital tract. Int Rev Cytol 47:137-194.
12. Cunha GR, Alarid ET, Turner T, Donjacour AA, Boutin EL, Foster BA 1992 Normal and abnormal development of the male urogenital tract. Role of androgens, mesenchymal-epithelial interactions, and growth factors. J Androl 13:465-475.
13. Culig Z, Hobisch A, Cronauer MV, Radmayr C, Hittmair A, Zhang J, Thurnher M, Bartsch G, Klocker H 1996 Regulation of prostatic growth and function by peptide growth factors. Prostate 28:392-405.
14. Story MT, Hopp KA, Meier DA, Begun FP, Lawson RK 1993 Influence of transforming growth factor β 1 and other growth factors on basic fibroblast growth factor level and proliferation of cultured human prostate-derived fibroblasts. Prostate 22:183-197.
15. Sugimura Y, Foster BA, Hom YK, Lipschutz JH, Rubin JS, Finch PW, Aaronson SA, Hayashi N, Kawamura J, Cunha GR 1996 Keratinocyte growth factor (KGF) can replace testosterone in the ductal branching morphogenesis of the rat ventral prostate. Int J Dev Biol 40:941-951.
16. Gingrich JR, Barrios RJ, Morton RA, Boyce BF, DeMayo FJ, Finegold MJ, Angelopoulou R, Rosen JM, Greenberg NM 1996 Metastatic prostate cancer in a transgenic mouse. Cancer Res 56:4096-4102.
17. Wang S, Gao J, Lei Q, Rozengurt N, Pritchard C, Jiao J, Thomas GV, Li G, Roy-Burman P, Nelson PS, Liu X, Wu H 2003 Prostatespecific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell 4:209-221.
18. Li L, Miano JM, Mercer B, Olson EN 1996 Expression of the SM22α promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells. J Cell Biol 132:849-859.
19. Holtwick R, Gotthardt M, Skryabin B, Steinmetz M, Potthast R, Zetsche B, Hammer RE, Herz J, Kuhn M 2002 Smooth muscleselective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure. Proc Natl Acad Sci USA 99:7142-7147.
20. Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S, Washington MK, Neilson EG, Moses HL 2004 TGF-β signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303:848-851.
21. Yeh S, Tsai MY, Xu Q, Mu XM, Lardy H, Huang KE, Lin H, Yeh SD, Altuwaijri S, Zhou X, Xing L, Boyce BF, Hung MC, Zhang S, Gan L, Chang C 2002 Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen functions in selective tissues. Proc Natl Acad Sci USA 99:13498-13503.
22. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA 2002 Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 3:349-363.
23. Darby I, Skalli O, Gabbiani G 1990 α-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest 63:21-29.
24. Singh R, Artaza JN, Taylor WE, Gonzalez-Cadavid NF, Bhasin S 2003 Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. Endocrinology 144:5081-5088.
25. Lawson DA, Xin L, Lukacs RU, Cheng D, Witte ON 2007 Isolation and functional characterization of murine prostate stem cells. Proc Natl Acad Sci USA 104:181-186.
26. Xin L, Ide H, Kim Y, Dubey P, Witte ON 2003 In vivo regeneration of murine prostate from dissociated cell populations of postnatal epithelia and urogenital sinus mesenchyme. Proc Natl Acad Sci USA 100(Suppl 1):11896-11903.
27. Litvinov IV, De Marzo AM, Isaacs JT 2003 Is the Achilles' heel for prostate cancer therapy a gain of function in androgen receptor signaling? J Clin Endocrinol Metab 88:2972-2982.
28. Leong KG, Wang BE, Johnson L, Gao WQ 2008 Generation of a prostate from a single adult stem cell. Nature 456:804-808.
29. Shaw A, Attia S, Bushman W 2008 Prostate stromal and urogenital sinus mesenchymal cell lines for investigations of stromal-epithelial interactions. Differentiation 76:599-605.
30. Shaw A, Papadopoulos J, Johnson C, Bushman W 2006 Isolation and characterization of an immortalized mouse urogenital sinus mesenchyme cell line. Prostate 66:1347-1358.
31. Jiao J, Wang S, Qiao R, Vivanco I, Watson PA, Sawyers CL, Wu H 2007 Murine cell lines derived from Pten null prostate cancer show the critical role of PTEN in hormone refractory prostate cancer development. Cancer Res 67:6083-6091.
32. Danielpour D, Kadomatsu K, Anzano MA, Smith JM, Sporn MB 1994 Development and characterization of nontumorigenic and tumorigenic epithelial cell lines from rat dorsal-lateral prostate. Cancer Res 54:3413-3421.
33. Ozer HL, Banga SS, Dasgupta T, Houghton J, Hubbard K, Jha KK, Kim SH, Lenahan M, Pang Z, Pardinas JR, Patsalis PC 1996 SV40-mediated immortalization of human fibroblasts. Exp Gerontol 31: 303-310.
34. Ittman M, Mansukhani A 1997 Expression of fibroblast growth factors (FGFs) and FGF receptors in human prostate. J Urol 157: 351-356.
35. Ropiquet F, Giri D, Lamb DJ, Ittmann M 1999 FGF7 and FGF2 are increased in benign prostatic hyperplasia and are associated with increased proliferation. J Urol 162:595-599.
36. Kitsberg DI, Leder P 1996 Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice. Oncogene 13:2507-2515.
37. Zhu ML, Kyprianou N 2008 Androgen receptor and growth factor signaling cross-talk in prostate cancer cells. Endocr Relat Cancer 15:841-849.
38. Itoh N, Patel U, Cupp AS, Skinner MK 1998 Developmental and hormonal regulation of transforming growth factor-β1 (TGFβ1), -2, and -3 gene expression in isolated prostatic epithelial and stromal cells: epidermal growth factor and TGFβ interactions. Endocrinology 139:1378-1388.
39. Lambertini E, Penolazzi L, Aguiari G, del Senno L, Pezzetti F, Sollazzo V, Piva R 2002 Osteoblastic differentiation induced by transcription factor decoy against estrogen receptor α gene. Biochem Biophys Res Commun 292:761-770.
40. Jiang M, Fernandez S, Jerome WG, He Y, Yu X, Cai H, Boone B, Yi Y, Magnuson MA, Roy-Burman P, Matusik RJ, Shappell SB, Hayward SW 2010 Disruption of PPARγ signaling results in mouse prostatic intraepithelial neoplasia involving active autophagy. Cell Death Differ 17:469-481.
41. Yu S, Yeh CR, Niu Y, Chang HC, Tsai YC, Moses HL, Shyr CR, Chang C, Yeh S 2011 Altered prostate epithelial development in mice lacking the androgen receptor in stromal fibroblasts. Prostate
42. Yu S, Zhang C, Lin CC, Niu Y, Lai KP, Chang HC, Yeh SD, Chang C, Yeh S 2011 Altered prostate epithelial development and IGF-1 signal in mice lacking the androgen receptor in stromal smooth muscle cells. Prostate 71:517-524.
43. Niu Y, Altuwaijri S, Lai KP, Wu CT, Ricke WA, Messing EM, Yao J, Yeh S, Chang C 2008 Androgen receptor is a tumor suppressor and proliferator in prostate cancer. Proc Natl Acad Sci USA 105: 12182-12187.
44. Niu Y, Altuwaijri S, Yeh S, Lai KP, Yu S, Chuang KH, Huang SP, Lardy H, Chang C 2008 Targeting the stromal androgen receptor in primary prostate tumors at earlier stages. Proc Natl Acad Sci USA 105:12188-12193.
45. Takeda H, Lasnitzki I, Mizuno T 1987 Change of mosaic pattern by androgens during prostatic bud formation in XTfm/X+ heterozygous female mice. J Endocrinol 114:131-137.
46. DiGiovanni J, Kiguchi K, Frijhoff A, Wilker E, Bol DK, Beltrán L, Moats S, Ramirez A, Jorcano J, Conti C 2000 Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice. Proc Natl Acad Sci USA 97:3455-3460.
47. Kaplan-Lefko PJ, Sutherland BW, Evangelou AI, Hadsell DL, Barrios RJ, Foster BA, Demayo F, Greenberg NM 2008 Enforced epithelial expression of IGF-1 causes hyperplastic prostate growth while negative selection is requisite for spontaneous metastogenesis. Oncogene 27:2868-2876.
48. Sutherland BW, Knoblaugh SE, Kaplan-Lefko PJ, Wang F, Holzenberger M, Greenberg NM 2008 Conditional deletion of insulin-like growth factor-I receptor in prostate epithelium. Cancer Res 68: 3495-3504.
49. Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico MG 1991 Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 88:9267-9271.
50. Park JE, Chen HH, Winer J, Houck KA, Ferrara N 1994 Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J Biol Chem 269:25646-25654.
51. Wang GM, Kovalenko B, Huang Y, Moscatelli D 2007 Vascular endothelial growth factor and angiopoietin are required for prostate regeneration. Prostate 67:485-499.
52. Denhardt DT, Giachelli CM, Rittling SR 2001 Role of osteopontin in cellular signaling and toxicant injury. Annu Rev Pharmacol Toxicol 41:723-749.
53. Thalmann GN, Sikes RA, Devoll RE, Kiefer JA, Markwalder R, Klima I, Farach-Carson CM, Studer UE, Chung LW 1999 Osteopontin: possible role in prostate cancer progression. Clin Cancer Res 5:2271-2277.
54. Hotte SJ, Winquist EW, Stitt L, Wilson SM, Chambers AF 2002 Plasma osteopontin: associations with survival and metastasis to bone in men with hormone-refractory prostate carcinoma. Cancer 95:506-512.
55. Lee C, Sintich SM, Mathews EP, Shah AH, Kundu SD, Perry KT, Cho JS, Ilio KY, Cronauer MV, Janulis L, Sensibar JA 1999 Transforming growth factor-β in benign and malignant prostate. Prostate 39:285-290.
56. Martikainen P, Kyprianou N, Isaacs JT 1990 Effect of transforming growth factor-β 1 on proliferation and death of rat prostatic cells. Endocrinology 127:2963-2968.
57. Itoh N, Patel U, Skinner MK 1998 Developmental and hormonal regulation of transforming growth factor-α and epidermal growth factor receptor gene expression in isolated prostatic epithelial and stromal cells. Endocrinology 139:1369-1377